We are thrilled to announce we will share five poster presentations with updated results from our different platforms at SITC from November 3-5, 2023 in San Diego!

Posters presented on Friday, Nov 3:

• Abstract 231: Differential effects of target ligands and receptor architecture upon NKG2D CAR T cell activation
• Abstract 285: Proof-of-concept of a non-gene editing technology using shRNA down-regulation to engineer and optimize CAR T-cell functionality
• Abstract 297: Improvement of CAR T-cell performance by simultaneous downregulation of multiple co-inhibitory receptors

Posters presented on Saturday, Nov 4:

• Abstract 232: NKG2D-based multi-specific CAR T-cells to overcome antigen escape and improve anti-tumor efficacy
• Abstract 298: A miRNA-based shRNA platform for the easy, safe, and effective generation of allogeneic CAR T-cells

See you there!!

Conference call at 7 a.m. ET / 1 p.m. CET

The Company management will host a conference call on Tuesday, September 05 at 1 p.m. CET / 7 a.m. ET to discuss half year 2023 financial results and provide an update on the Company’s recent changes and upcoming milestones.

Participants may access the conference call either:

• by dialing +1-877-407-9716 or +1-201-493-6779 (United States, International), +32 (0) 800-73-904  (Belgium Fixed) or +32 (0) 800-73-566 (Belgium Mobile). Please dial into the call five to ten minutes prior to start time using the appropriate number and ask to join the “Celyad Oncology SA call”
• by clicking the “call me” link for instant telephone access to the event
• or by connecting via live webcast link for instant webcast access to the event

Archived recording will be available on this website after the event.

Our lead scientists Jennifer Bolsée and Matteo Rossi will provide an update on our NKG2D-based multi-specific CAR T-cells and multiplex shRNA platform at the ICLE 2023 conference poster session in Munich.

If you want to know more about our platforms and CAR T-cell candidates, come to see their poster and discuss with them!

 

Our team will be attending BioJapan, the Asia’s main partnering event in Yokohama!

Our CEO Georges Rawadi will be present at this gathering of the global biotech community and will be happy to meet you there!

Find our company in the partnering system for potential meetings!

Our team will be attending the 8th CAR-TCR Summit in Boston, MA!

If you pass by, come to see our poster and meet the team!